BiVictriX Therapeutics PLC

Here is the public summary page for BiVictriX Therapeutics PLC. Please login to see the complete information for BiVictriX Therapeutics PLC including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how BiVictriX Therapeutics PLC stacks up relative to its peers.


Darwin Score+4
TickerBVX
Latest Price0.10 GBP as of close on 10-Sep-2024
3 Month price range0.08 to 0.13 GBP
Market Capitalisation8.25Mn GBP
CountryUK
RegionEurope
Economic SectorHealth Care
Business SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryBiotechnology
Sub-IndustryBiotechnology
Description
BiVictriX Therapeutics plc, a biotechnology company, engages in the research and experimental development of pharmaceutical products in the United Kingdom. The company develops Bi-Cygni, a proprietary platform that combines the discovery of novel, cancer-selective twin-antigen pairs or fingerprints with bispecific antibody engineering insights to create anti-cancer therapeutics. Its lead program is BVX001, a first-in-class Bi Cygni antibody drug conjugates to treat acute myeloid leukemia. The company also develops BVX002 for treating ovarian and other solid tumors; and BVX003 for bladder and other solid tumors. The company was formerly known as BiVictriX plc and changed its name to BiVictriX Therapeutics plc in August 2021. BiVictriX Therapeutics plc was founded in 2016 and is headquartered in Macclesfield, the United Kingdom.
See More ...
Company URLhttps://www.bivictrix.com
See Darwins Full Analysis for BiVictriX Therapeutics PLC

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for BiVictriX Therapeutics PLC. Further information and full detail is available when you login.

TMA PartFocus of AnalysisTMA Score
PriceAnalysis of performance, trend, RSI, OBV and moving averages+6
SentimentNews and Candle Patterns. +1
FundamentalsAnalyst Ratings, Valuation and Dividend analysis.0
FlowInstitutional, Fund and Insider buying and selling.0
ModelsForecast models.-3

Alerts

There are 11 live alerts for BiVictriX Therapeutics PLC.


Peer Comparison

There are 28 peers of BiVictriX Therapeutics PLC.
Asset NameIndustry GroupPerf(20d)%Asset Score
4BASEBIO UK SOCIETAS (4BB)Biotechnology-14.2-15
Abingdon Health Plc (ABDX)Biotechnology-3.7+3
Alliance Pharma plc (APH)Biotechnology+0.8+34
Angle PLC (AGL)Biotechnology-12.7-19
Aptamer Group PLC (APTA)Biotechnology+22.6+11
Arecor Therapeutics PLC (AREC)Biotechnology+3.1+7
Avacta Group PLC (AVCT)Biotechnology-26.1-14
BSF Enterprise Plc (BSFA)Biotechnology-90.1+1
Benchmark Holdings Plc (BMK)Biotechnology-16.1-16
Beximco Pharmaceuticals Limited (BXP)Biotechnology+11.8+16
Bioventix (BVXP)Biotechnology+2.9-9
Chill Brands Group PLC (CHLL)Biotechnology-29.4-23
Cizzle Biotechnology Holdings PLC (CIZ)Biotechnology-3.1+2
Destiny Pharma PLC (DEST)Biotechnology-7.7-30
Diaceutics PLC (DXRX)Biotechnology+1.8+22
Evgen Pharma PLC (EVG)Biotechnology-8.6-7
Faron Pharmaceuticals Oy (FARN)Biotechnology0-24
Genflow Biosciences plc (GENF)Biotechnology+15.9+21
Genincode PLC (GENI)Biotechnology-32.1-22
Genus PLC (GNS)Biotechnology+4.0+16
Haleon PLC (HLN)Biotechnology+2.1+31
Ondine Biomedical Inc (OBI)Biotechnology-22.0-23
Oxford BioMedica PLC (OXB)Biotechnology+28.4+43
Oxford Nanopore Technologies PLC (ONT)Biotechnology+22.2+11
Physiomics PLC (PYC)Biotechnology+5.7-19
Shield Therapeutics PLC (STX)Biotechnology+14.6+37
e-therapeutics plc (ETX)Biotechnology-28.0-4
genedrive plc (GDR)Biotechnology-15.0-9

Share Share on Facebook Share on Twitter Share on Threads Share on LinkedIn